In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Comparative Analyses with DPP-4 Inhibitors, Including Sitagliptin, and Findings on Use in Weight Management and Type 1 Diabetes Underscore Janssen Commitment to Improving Diabetes Management
First of its kind, two-year, 200-patient NEXT-2 trial utilized Guardant360 testing for therapy selection, and studied clinical response rates across multiple cancer types, including lung, gastric, melanoma, and rare cancers
Game-changing MALDI PharmaPulse (MPP) Solution Enables Mass Spectrometry-based Label-Free Ultra-High Throughput Screening for Primary Screens on Millions of Compounds in Drug Discovery
Unique Trapped Ion Mobility Spectrometry (TIMS) Coupled to Bruker's High-Performance QTOF Mass Spectrometry Enables High-Resolution Compound Separation, Significant Duty Cycle Enhancements and Studies of Protein Conformations, Aggregation and Structural Isomers
Data Reinforces BERG's Commitment to Improving the Standard of Care for Cancer Patients by Combining Biology with Artificial Intelligence for Next-Generation Precision Medicine
Four New Analyses of SEER Registry Provide Additional Evidence that Oncotype DX Accurately Predicts Patient Outcomes in Node-negative and Node-positive Breast Cancer and Reinforce Its Value in Older Women
- Phase 3 data from the MMY3004 (CASTOR) trial to be featured in the Plenary Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract #LBA4)
- Secondary objective demonstrated one-year overall survival rate in 32 percent of patients identified with high expression of delta-like protein 3 (DLL3) SCLC
Patient Database Reveals Under-Utilization of Targeted Therapies in Certain Lung Cancer Mutations, Identifies Higher-Risk Stage 1 Breast Cancer Patients Who May Benefit from Adjuvant Chemotherapy